- Are Requip and Rytary the Same Thing?
- What Are Possible Side Effects of Requip?
- What Are Possible Side Effects of Rytary?
- What Is Requip?
- What Is Rytary?
- What Drugs Interact with Requip?
- What Drugs Interact with Rytary?
- How Should Requip Be Taken?
- How Should Rytary Be Taken?
Are Requip and Rytary the Same Thing?
Side effects of Requip that are different from Rytary include stomach pain, loss of appetite, worsened RLS symptoms early in the morning, diarrhea, sweating, drowsiness, agitation, flushing, weakness, chest pain, leg swelling, high or low blood pressure, lightheadedness or fainting, muscle spasm, numbness, spinning sensation, abdominal pain, indigestion, gas, palpitations, fast heart rate, sore throat, urinary tract infection (UTI), or vision problems.
Both Requip and Rytary may interact with metoclopramide.
Requip may also interact with alcohol, other drugs that make you sleepy (sleeping pills, narcotics, muscle relaxers, or medicines for anxiety, depression, or seizures), levodopa, ciprofloxacin, fluvoxamine, omeprazole, medications used to treat nausea and vomiting, medications used to treat mental illness, or estrogen.
Withdrawal symptoms may occur if you suddenly stop taking Requip.
What Are Possible Side Effects of Requip?
Common side effects of Requip include:
- stomach pain,
- loss of appetite,
- worsened RLS symptoms early in the morning,
- dry mouth,
- sleep problems (insomnia),
- chest pain,
- leg swelling,
- high or low blood pressure,
- lightheadedness or fainting,
- muscle spasm,
- spinning sensation,
- abdominal pain,
- fast heart rate,
- sore throat,
- urinary tract infection, or
- vision problems.
What Are Possible Side Effects of Rytary?
Common side effects of Rytary include:
- abnormal dreams,
- dry mouth,
- involuntary movements,
- vomiting, and
- low blood pressure and dizziness upon standing (orthostatic hypotension)
What Is Requip?
Requip (ropinirole) is a non-ergoline dopamine agonist used to treat symptoms of Parkinson's disease, such as stiffness, tremors, muscle spasms, and poor muscle control. Requip is also used to treat restless legs syndrome (RLS). Requip is available in generic form.
What Is Rytary?
Rytary (carbidopa and levodopa) is a combination an inhibitor of aromatic amino acid decarboxylation and an aromatic amino acid, used for the treatment of Parkinson's disease, post-encephalitic Parkinsonism, and Parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
What Drugs Interact With Requip?
Requip may interact with levodopa, ciprofloxacin, fluvoxamine, metoclopramide, omeprazole, medication used to treat nausea and vomiting or mental illness, or estrogen. Tell your doctor all medications you use. During pregnancy, Requip should be used only if prescribed. It is not known whether this medication passes into breast milk or if it could harm a nursing baby. Requip may reduce breast milk production. Consult your doctor before breast-feeding. Withdrawal symptoms such as fever, muscle stiffness, and confusion may occur if you stop the medication suddenly or if you change doses.
What Drugs Interact With Rytary?
Rytary may interact with MAO inhibitors, phenothiazines, butyrophenones, risperidone, metoclopramide, isoniazid, iron salts, or multi-vitamins containing iron salts. Tell your doctor all medications and supplements you use. During pregnancy, Rytary should be used only if prescribed. These drugs may pass into breast milk. Consult your doctor before breastfeeding.
How Should Requip Be Taken?
The recommended dose of Requip is 40 to 320 mcg twice daily for adults and 40 to 80 mcg twice daily for children. If you are also using a bronchodilator, use it first before using the beclomethasone inhaler. There may be other drugs that can interact with Requip.
How Should Rytary Be Taken?
The recommended starting dosage of Rytary is 23.75 mg/95 mg taken orally three times a day for the first 3 days. On the fourth day of treatment, the dosage of Rytary may be increased to 36.25 mg/145 mg taken three times a day.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
GSK. Requip Product Information.
Impax Laboratories, Inc. Rytary Product Information.